What is Elemind?
Elemind is a neurotechnology company focused on developing products that leverage novel neuromodulation techniques. These techniques are designed to shape brainwaves and alter brain states, positioning Elemind at the forefront of brain-computer interface and cognitive enhancement technologies. The company's innovative approach aims to address a wide range of applications within the burgeoning neurotech market.
How much funding has Elemind raised?
Elemind has raised a total of $12M across 1 funding round:
Angel/Seed
$12M
Angel/Seed (2024): $12M with participation from Embark Ventures, LDV Partners, villageglobal.com, and Wharton Alumni Angels
Key Investors in Elemind
Embark Ventures
Embark Ventures is a venture capital fund specializing in pre-seed and seed stage investments in deep tech companies, focusing on ambitious teams with breakthrough proprietary technology capable of transforming multi-billion dollar industries.
LDV Partners
LDV Partners collaborates closely with visionary founders, providing strategic insights and resources to foster growth in disruptive technologies, with a focus on AI and life sciences.
villageglobal.com
Village Global VC is an early-stage venture capital firm that supports startups with funding, mentorship, and access to a network of successful entrepreneurs and investors, investing in resourceful founders globally.
What's next for Elemind?
With this substantial infusion of capital, Elemind is poised for accelerated growth and product development. The strategic investment suggests confidence from backers in the company's long-term vision and market potential. Future initiatives will likely focus on scaling operations, expanding research and development efforts, and potentially bringing their neurotechnology products to a broader market. This funding round is a critical step in solidifying Elemind's position as a leader in shaping brainwave technology.
See full Elemind company page
